A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
PHASE3
This is an efficacy and safety study of ertugliflozin in participants with ...
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-2)
PHASE3
The purpose of this study is to determine if LY2189265 is effective in redu...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Efficacy and Safety of Ertugliflozin (MK-8835/PF-04971729) With Sitagliptin in the Treatment of Participants With Type 2 Diabetes Mellitus (T2DM) With Inadequate Glycemic Control on Diet and Exercise (MK-8835-017)
PHASE3
This is a study to evaluate the efficacy and safety of ertugliflozin (MK-88...